Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bodner

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Blood|February 1, 1985
Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrateJ J Goedert, M G Sarngadharan, M E Eyster, et al.
Annals of Internal Medicine|January 1, 1989
Thrombotic thrombocytopenic purpura and human T-lymphotrophic virus, type 1 (HTLV-1)A C Dixon, D W Kwock, J M Nakamura, et al.
The American Journal of Drug and Alcohol Abuse|January 1, 1987
Serologic, immunologic, and clinical features of parenteral drug users from contrasting populationsD Shine, B Moll, E Emeson, et al.
Atherosclerosis|October 5, 2001
Flow-mediated, endothelium-dependent vasodilatation is impaired in male body builders taking anabolic-androgenic steroidsC F Ebenbichler, W Sturm, H Gänzer, et al.
Journal of Natural Products|July 1, 1989
Anti-AIDS agents, 1. Isolation and characterization of four new tetragalloylquinic acids as a new class of HIV reverse transcriptase inhibitors from tannic acidM Nishizawa, T Yamagishi, G E Dutschman, et al.
Journal of Medicinal Chemistry|June 24, 2015
Biological Efficacy and Toxicity of Diamidines in Myotonic Dystrophy Type 1 ModelsRuth B Siboni, Micah J Bodner, Muhammad M Khalifa, et al.
British Medical Journal (Clinical Research Ed.)|March 16, 1985
Seroepidemiology of HTLV-III antibodies in a remote population of eastern ZaireR J Biggar, M Melbye, L Kestens, et al.
The Journal of Infectious Diseases|October 1, 1986
Association of HTLV-III with Epstein-Barr virus infection and abnormalities of T lymphocytes in homosexual menC R Rinaldo, L A Kingsley, D W Lyter, et al.
International Journal of Cancer|June 15, 1985
Regional variation in prevalence of antibody against human T-lymphotropic virus types I and III in Kenya, East AfricaR J Biggar, B K Johnson, C Oster, et al.
American Journal of Epidemiology|June 1, 1991
Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinantsE L Murphy, J P Figueroa, W N Gibbs, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Blood|February 1, 1985
Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrateJ J Goedert, M G Sarngadharan, M E Eyster, et al.
Annals of Internal Medicine|January 1, 1989
Thrombotic thrombocytopenic purpura and human T-lymphotrophic virus, type 1 (HTLV-1)A C Dixon, D W Kwock, J M Nakamura, et al.
The American Journal of Drug and Alcohol Abuse|January 1, 1987
Serologic, immunologic, and clinical features of parenteral drug users from contrasting populationsD Shine, B Moll, E Emeson, et al.
Atherosclerosis|October 5, 2001
Flow-mediated, endothelium-dependent vasodilatation is impaired in male body builders taking anabolic-androgenic steroidsC F Ebenbichler, W Sturm, H Gänzer, et al.
Journal of Natural Products|July 1, 1989
Anti-AIDS agents, 1. Isolation and characterization of four new tetragalloylquinic acids as a new class of HIV reverse transcriptase inhibitors from tannic acidM Nishizawa, T Yamagishi, G E Dutschman, et al.
Journal of Medicinal Chemistry|June 24, 2015
Biological Efficacy and Toxicity of Diamidines in Myotonic Dystrophy Type 1 ModelsRuth B Siboni, Micah J Bodner, Muhammad M Khalifa, et al.
British Medical Journal (Clinical Research Ed.)|March 16, 1985
Seroepidemiology of HTLV-III antibodies in a remote population of eastern ZaireR J Biggar, M Melbye, L Kestens, et al.
The Journal of Infectious Diseases|October 1, 1986
Association of HTLV-III with Epstein-Barr virus infection and abnormalities of T lymphocytes in homosexual menC R Rinaldo, L A Kingsley, D W Lyter, et al.
International Journal of Cancer|June 15, 1985
Regional variation in prevalence of antibody against human T-lymphotropic virus types I and III in Kenya, East AfricaR J Biggar, B K Johnson, C Oster, et al.
American Journal of Epidemiology|June 1, 1991
Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinantsE L Murphy, J P Figueroa, W N Gibbs, et al.
Pageof 9